FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

766728007: Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet (clinical drug)


Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3662412011 Acetaminophen 500 mg and phenyltoloxamine citrate 30 mg oral tablet en Synonym Active Case insensitive SNOMED CT core
3662414012 Paracetamol 500 mg and phenyltoloxamine citrate 30 mg oral tablet en Synonym Active Case insensitive SNOMED CT core
3681712017 Product containing precisely paracetamol 500 milligram and phenyltoloxamine citrate 30 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Case insensitive SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Paracetamol 500 mg and phenyltoloxamine citrate 30 mg oral tablet Is a Paracetamol and phenyltoloxamine only product in oral dose form true Inferred relationship Some
Paracetamol 500 mg and phenyltoloxamine citrate 30 mg oral tablet Has precise active ingredient Phenyltoloxamine citrate true Inferred relationship Some 1
Paracetamol 500 mg and phenyltoloxamine citrate 30 mg oral tablet Has BoSS Phenyltoloxamine citrate true Inferred relationship Some 1
Paracetamol 500 mg and phenyltoloxamine citrate 30 mg oral tablet Has precise active ingredient Paracetamol true Inferred relationship Some 2
Paracetamol 500 mg and phenyltoloxamine citrate 30 mg oral tablet Has BoSS Paracetamol true Inferred relationship Some 2
Paracetamol 500 mg and phenyltoloxamine citrate 30 mg oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Some 2
Paracetamol 500 mg and phenyltoloxamine citrate 30 mg oral tablet Has presentation strength numerator unit mg true Inferred relationship Some 1
Paracetamol 500 mg and phenyltoloxamine citrate 30 mg oral tablet Has presentation strength numerator unit mg true Inferred relationship Some 2
Paracetamol 500 mg and phenyltoloxamine citrate 30 mg oral tablet Has presentation strength denominator value 1 false Inferred relationship Some 1
Paracetamol 500 mg and phenyltoloxamine citrate 30 mg oral tablet Has manufactured dose form Conventional release oral tablet true Inferred relationship Some
Paracetamol 500 mg and phenyltoloxamine citrate 30 mg oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Some 1
Paracetamol 500 mg and phenyltoloxamine citrate 30 mg oral tablet Has presentation strength denominator value 1 false Inferred relationship Some 2
Paracetamol 500 mg and phenyltoloxamine citrate 30 mg oral tablet Has presentation strength numerator value 500 false Inferred relationship Some 1
Paracetamol 500 mg and phenyltoloxamine citrate 30 mg oral tablet Has BoSS Paracetamol false Inferred relationship Some 1
Paracetamol 500 mg and phenyltoloxamine citrate 30 mg oral tablet Has BoSS Phenyltoloxamine citrate false Inferred relationship Some 2
Paracetamol 500 mg and phenyltoloxamine citrate 30 mg oral tablet Has presentation strength numerator value 30 false Inferred relationship Some 2
Paracetamol 500 mg and phenyltoloxamine citrate 30 mg oral tablet Has unit of presentation Tablet true Inferred relationship Some
Paracetamol 500 mg and phenyltoloxamine citrate 30 mg oral tablet Has precise active ingredient Phenyltoloxamine citrate false Inferred relationship Some 2
Paracetamol 500 mg and phenyltoloxamine citrate 30 mg oral tablet Has precise active ingredient Paracetamol false Inferred relationship Some 1
Paracetamol 500 mg and phenyltoloxamine citrate 30 mg oral tablet Is a Paracetamol- and phenyltoloxamine-containing product in oral dose form false Inferred relationship Some
Paracetamol 500 mg and phenyltoloxamine citrate 30 mg oral tablet Count of base of active ingredient 2 false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start